Ligand validation:3LQ4

TPP: THIAMINE DIPHOSPHATE

TPP is a Ligand Of Interest in 3LQ4 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3LQ4_TPP_B_887	84%	32%	0.114	0.975	1.64	1.06	6	1	2	0	100%	0.9058
3LQ4_TPP_A_887	67%	32%	0.135	0.945	1.62	1.08	6	1	6	0	100%	0.7446
2QTA_TPP_B_887	91%	28%	0.081	0.967	1.9	1	8	1	1	0	100%	1
2IEA_TPP_B_887	88%	30%	0.098	0.974	1.75	1.05	6	1	2	0	100%	1
3LPL_TPP_B_887	52%	31%	0.113	0.975	1.62	1.16	1	1	1	0	42%	0.4231
3LQ2_TPP_B_887	47%	32%	0.2	0.941	1.64	1.06	6	1	2	0	100%	0.6942
2AG1_TPP_D_632	100%	1%	0.016	0.998	6	2.06	5	8	0	0	100%	1
9BT4_TPP_C_302	100%	48%	0.018	0.998	1.1	0.92	2	2	1	0	100%	1
4KXW_TPP_A_1015	100%	39%	0.032	0.998	1.23	1.16	2	4	1	0	100%	1
4KGD_TPP_A_704	100%	22%	0.035	0.997	1.74	1.51	4	7	0	0	100%	0.97
4MPJ_TPP_A_604	100%	28%	0.031	0.991	1.34	1.53	3	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.